Suppr超能文献

骶神经调节的预测因素:系统评价。

Predictive Factors in Sacral Neuromodulation: A Systematic Review.

机构信息

Department of Urology, Maastricht University Medical Centre (MUMC+), Mastricht, The Netherlands.

Pelvic Care Centre Maastricht, Maastricht University Medical Centre (MUMC+), Mastricht, The Netherlands.

出版信息

Urol Int. 2022;106(4):323-343. doi: 10.1159/000513937. Epub 2021 May 31.

Abstract

INTRODUCTION

Sacral neuromodulation (SNM) is an effective treatment in patients with overactive bladder syndrome or nonobstructive urinary retention when conservative treatment fails. Several factors that could impact outcome with SNM have been studied. This systematic review investigated these predictive factors and their relevance for clinical practice.

METHODS

Systematic review according to the PRISMA guidelines was conducted. This review is registered in the PROSPERO register (CRD42015016256).

RESULTS

Seventy-eight studies (of which 11 abstracts) were included. Females, younger patients, and a tined lead procedure tend to be predictive in successful SNM outcome. Factors that did not influence SNM outcome were prior back surgery, surgery for stress urinary incontinence, affective symptoms, and duration of complaints. Reduced detrusor contractility is associated with a lower success rate. The level of evidence of most studies (graded according to the Centre for Evidence-Based Medicine) was 3b.

CONCLUSION

Even though this systematic review investigated predictive factors (gender, age, type of procedure, type of lead, and detrusor contractility), no general consensus on predictive factors could be made. Most studies are small, retrospective, and involve a heterogeneous population. Therefore, prospective research in larger specific patient groups remains necessary to find predictors of SNM outcome.

摘要

简介

骶神经调节(SNM)是一种有效的治疗方法,适用于保守治疗失败的膀胱过度活动症或非梗阻性尿潴留患者。已经研究了多种可能影响 SNM 治疗效果的因素。本系统评价调查了这些预测因素及其对临床实践的相关性。

方法

根据 PRISMA 指南进行系统评价。本综述在 PROSPERO 注册中心(CRD42015016256)进行了注册。

结果

共纳入 78 项研究(其中 11 项摘要)。女性、年轻患者和使用带刺电极的手术程序往往是 SNM 治疗成功的预测因素。不会影响 SNM 治疗效果的因素包括既往背部手术、治疗压力性尿失禁的手术、情感症状以及症状持续时间。逼尿肌收缩力降低与较低的成功率相关。根据循证医学中心(Centre for Evidence-Based Medicine)的分级,大多数研究的证据水平为 3b 级。

结论

尽管本系统评价调查了预测因素(性别、年龄、手术类型、电极类型和逼尿肌收缩力),但仍无法就预测因素达成普遍共识。大多数研究规模较小、回顾性且涉及异质性人群。因此,仍需要对更大的特定患者群体进行前瞻性研究,以找到 SNM 治疗效果的预测因素。

相似文献

1
Predictive Factors in Sacral Neuromodulation: A Systematic Review.
Urol Int. 2022;106(4):323-343. doi: 10.1159/000513937. Epub 2021 May 31.
2
3
Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
Neurourol Urodyn. 2019 Aug;38(6):1595-1601. doi: 10.1002/nau.24018. Epub 2019 May 1.
4
Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects.
Expert Rev Med Devices. 2022 Feb;19(2):161-187. doi: 10.1080/17434440.2022.2032655. Epub 2022 Feb 6.
5
Sensing in Sacral Neuromodulation: A Feasibility Study in Subjects With Urinary Incontinence and Retention.
Neuromodulation. 2024 Feb;27(2):392-398. doi: 10.1016/j.neurom.2023.07.002. Epub 2023 Aug 16.
6
Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?
Neuromodulation. 2017 Dec;20(8):830-835. doi: 10.1111/ner.12649. Epub 2017 Sep 6.
7
Two-Staged Sacral Neuromodulation for the Treatment of Nonobstructive Urinary Retention: A Multicenter Study Assessing Predictors of Success.
Neuromodulation. 2023 Dec;26(8):1823-1830. doi: 10.1016/j.neurom.2022.04.042. Epub 2022 Jun 9.
9
Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
J Urol. 2018 Jun;199(6):1584-1590. doi: 10.1016/j.juro.2017.12.053. Epub 2017 Dec 29.
10
[Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Urologe A. 2010 Oct;49(10):1254-9. doi: 10.1007/s00120-010-2395-4.

引用本文的文献

5
The mechanism of action of neuromodulation in the treatment of overactive bladder.
Nat Rev Urol. 2024 Dec 9. doi: 10.1038/s41585-024-00967-8.
6
Long-term Outcomes of Periurethral Sphincter Botulinum Toxin in Female Chronic Urinary Retention.
Int Neurourol J. 2024 Sep;28(3):207-214. doi: 10.5213/inj.2448176.088. Epub 2024 Sep 30.
7
Predicting success using response after lead implantation with sacral neuromodulation for urgency incontinence.
Neurourol Urodyn. 2024 Nov;43(8):1776-1783. doi: 10.1002/nau.25562. Epub 2024 Jul 29.
10
Third-line therapy for overactive bladder in the elderly: Nuances and considerations.
Neurourol Urodyn. 2022 Nov;41(8):1967-1974. doi: 10.1002/nau.24965. Epub 2022 May 29.

本文引用的文献

2
Sacral neuromodulation for overactive bladder in women: do age and comorbidities make a difference?
Int Urogynecol J. 2021 Jan;32(1):149-157. doi: 10.1007/s00192-020-04392-4. Epub 2020 Jun 25.
5
Do Failure of Posterior Tibial Nerve Stimulation Precludes to Use Sacral Neuromodulation in Patient With Overactive Bladder?
Int Neurourol J. 2019 Dec;23(4):287-293. doi: 10.5213/inj.1938118.059. Epub 2019 Dec 31.
6
Outcomes of Sacral Nerve Stimulation for Treatment of Refractory Overactive Bladder Among Octogenarians.
Neuromodulation. 2019 Aug;22(6):738-744. doi: 10.1111/ner.12981. Epub 2019 Jun 19.
7
Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
Neurourol Urodyn. 2019 Aug;38(6):1595-1601. doi: 10.1002/nau.24018. Epub 2019 May 1.
9
Statewide Success of Staged Sacral Neuromodulation for the Treatment of Urinary Complaints in California (2005-2011).
Female Pelvic Med Reconstr Surg. 2020 Jul;26(7):437-442. doi: 10.1097/SPV.0000000000000605.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验